How much revenue did Aptinyx generate this year?
Aptinyx has achieved a revenue of 0 USD this year.
Aptinyx Revenue 2024
Aptinyx Revenue
0 USD
Ticker
APTX
ISIN
US03836N1037
WKN
A2JPB1
In 2024, Aptinyx's sales reached 0 USD, a 0% difference from the 0 USD sales recorded in the previous year.
The Aptinyx Revenue history
| YEAR | REVENUE (undefined USD) | GROSS MARGIN (%) |
|---|---|---|
| 2028e | 142.8 | - |
| 2027e | 374.85 | - |
| 2026e | - | - |
| 2025e | - | - |
| 2024e | - | - |
| 2023e | - | - |
| 2022 | - | - |
| 2021 | 1 | - |
| 2020 | 1.56 | - |
| 2019 | 3.67 | - |
| 2018 | 6.57 | - |
| 2017 | 4.96 | - |
| 2016 | 9.79 | - |
Aptinyx Revenue, EBIT, Net Income US03836N1037 · A2JPB1
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Aptinyx, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Aptinyx from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Aptinyx’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Aptinyx. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Aptinyx’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Aptinyx’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Aptinyx’s growth potential.
Aptinyx Revenue, EBIT and net profit per share
| Date | Aptinyx Revenue | Aptinyx EBIT | Aptinyx Net Income |
|---|---|---|---|
| 2028e | 142.8 M undefined | 0 undefined | -31.08 M undefined |
| 2027e | 374.85 M undefined | -40.19 M undefined | -31.08 M undefined |
| 2026e | 0 undefined | -38.25 M undefined | -15.89 M undefined |
| 2025e | 0 undefined | -73.29 M undefined | -30.39 M undefined |
| 2024e | 0 undefined | -52.42 M undefined | -30.39 M undefined |
| 2023e | 0 undefined | -45.44 M undefined | -32.46 M undefined |
| 2022 | 0 undefined | -62.57 M undefined | -64.85 M undefined |
| 2021 | 1 M undefined | -74.53 M undefined | -74.89 M undefined |
| 2020 | 1.56 M undefined | -50.77 M undefined | -50.05 M undefined |
| 2019 | 3.67 M undefined | -59.61 M undefined | -57.41 M undefined |
| 2018 | 6.57 M undefined | -54.89 M undefined | -53.28 M undefined |
| 2017 | 4.96 M undefined | -32.23 M undefined | -32.07 M undefined |
| 2016 | 9.79 M undefined | -17.72 M undefined | -15.48 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2016 | 9.79 M USD | -17.72 M USD | -15.48 M USD |
| 2017 | 4.96 M USD | -32.23 M USD | -32.07 M USD |
| 2018 | 6.57 M USD | -54.89 M USD | -53.28 M USD |
| 2019 | 3.67 M USD | -59.61 M USD | -57.41 M USD |
| 2020 | 1.56 M USD | -50.77 M USD | -50.05 M USD |
| 2021 | 1 M USD | -74.53 M USD | -74.89 M USD |
| 2022 | 0 USD | -62.57 M USD | -64.85 M USD |
| 2023e | 0 USD | -45.44 M USD | -32.46 M USD |
| 2024e | 0 USD | -52.42 M USD | -30.39 M USD |
| 2025e | 0 USD | -73.29 M USD | -30.39 M USD |
| 2026e | 0 USD | -38.25 M USD | -15.89 M USD |
| 2027e | 374.85 M USD | -40.19 M USD | -31.08 M USD |
| 2028e | 142.8 M USD | 0 USD | -31.08 M USD |
Aptinyx stock margins US03836N1037 · A2JPB1
The Aptinyx margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Aptinyx. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Aptinyx.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Aptinyx's sales revenue. A higher gross margin percentage indicates that the Aptinyx retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Aptinyx's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Aptinyx's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Aptinyx's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Aptinyx. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Aptinyx's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Aptinyx Margin History
| Aptinyx Gross margin | Aptinyx Profit margin | Aptinyx EBIT margin | Aptinyx Profit margin |
|---|---|---|---|
| 2028e | 0 % | 0 % | -21.77 % |
| 2027e | 0 % | -10.72 % | -8.29 % |
| 2026e | 0 % | 0 % | 0 % |
| 2025e | 0 % | 0 % | 0 % |
| 2024e | 0 % | 0 % | 0 % |
| 2023e | 0 % | 0 % | 0 % |
| 2022 | 0 % | 0 % | 0 % |
| 2021 | 0 % | -7,453 % | -7,489 % |
| 2020 | 0 % | -3,254.49 % | -3,208.33 % |
| 2019 | 0 % | -1,624.25 % | -1,564.31 % |
| 2018 | 0 % | -835.46 % | -810.96 % |
| 2017 | 0 % | -649.8 % | -646.57 % |
| 2016 | 0 % | -181 % | -158.12 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2016 | 0 % | -181 % | -158.12 % |
| 2017 | 0 % | -649.8 % | -646.57 % |
| 2018 | 0 % | -835.46 % | -810.96 % |
| 2019 | 0 % | -1,624.25 % | -1,564.31 % |
| 2020 | 0 % | -3,254.49 % | -3,208.33 % |
| 2021 | 0 % | -7,453 % | -7,489 % |
| 2022 | 0 % | 0 % | 0 % |
| 2023e | 0 % | 0 % | 0 % |
| 2024e | 0 % | 0 % | 0 % |
| 2025e | 0 % | 0 % | 0 % |
| 2026e | 0 % | 0 % | 0 % |
| 2027e | 0 % | -10.72 % | -8.29 % |
| 2028e | 0 % | 0 % | -21.77 % |
Aptinyx Aktienanalyse
What does Aptinyx do?
Aptinyx Inc is a biopharmaceutical company specializing in the development of therapies for the treatment of neurological diseases. The company was founded in 2015 in Evanston, Illinois, USA, and has since achieved an impressive track record in researching and developing innovative therapies. The history of Aptinyx Inc begins with a group of experienced scientists and researchers who came together to push the boundaries of neuroscience research and discover new treatment options for people with brain disorders. The company is based on the belief that the human brain is a fascinating and complex entity that still holds many secrets. The company is committed to improving human well-being through innovative neurotherapeutic products and services. Aptinyx Inc's business model focuses on the research, development, and commercialization of novel therapeutic treatments for neurological diseases. The company closely collaborates with leading academic institutions and facilities to leverage the best research findings and methods. The company has a strong scientific foundation led by an experienced team of researchers and developers working on innovative biomarker and therapy strategies. Aptinyx Inc has focused on the development of neuromodulators and neuroprotectants to treat neurological diseases, including pain disorders, peripheral neuropathies, neuropathic pain, Parkinson's disease, post-traumatic stress disorder (PTSD), and other central nervous system disorders. Aptinyx Inc's products are based on a comprehensive understanding of the fundamentals of the nervous system and how it functions. The company offers a variety of products and services, including novel therapeutics for the treatment of pain, neuropathy, and other neurological diseases. These products are based on the utilization of Aptinyx's proprietary technologies to selectively modulate specific cell types and signaling pathways in the nervous system. The products and services of Aptinyx Inc have been regulated by leading health authorities in the US and Europe. Aptinyx Inc has two main divisions of products: the first focus is on the development of neuromodulators that specifically alleviate pain and modulate the brain. The second focus is on the development of neuroprotectants that help protect neurons and reduce inflammation in the nervous system. These two divisions are closely interconnected as they are based on a common platform grounded in the exploration of novel biomarkers and therapeutic targets. The products of Aptinyx Inc are designed for both pain relief and improvement of neural functions. Additionally, these products aim to enhance patient experience and quality of life. The company consistently collaborates with potential partners and experts to develop products tailored to the needs of patients and healthcare providers. Overall, Aptinyx Inc has revolutionized the world of neuroscience by exploring and developing innovative solutions for neurological diseases. The company has achieved an impressive track record by utilizing its scientific expertise and groundbreaking technologies to set new trends in neuroscience research and therapeutics. In summary, Aptinyx Inc has developed a unique approach to the development of neuromodulators and neuroprotectants based on a deep understanding of the structure and function of the nervous system. The products and services of the company have the potential to play a significant role in improving the quality of life for patients with neurological diseases. Aptinyx ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Aptinyx's Sales Figures
The sales figures of Aptinyx originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Aptinyx’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Aptinyx's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Aptinyx’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Aptinyx stock
How much was the turnover of the company Aptinyx compared to the previous year?
The revenue of Aptinyx has increased by 0% decreased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Aptinyx?
The revenue of Aptinyx is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Aptinyx measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Aptinyx so important for investors?
The revenue of Aptinyx is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Aptinyx pay?
Over the past 12 months, Aptinyx paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Aptinyx is expected to pay a dividend of 0 USD.
What is the dividend yield of Aptinyx?
The current dividend yield of Aptinyx is .
When does Aptinyx pay dividends?
Aptinyx pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Aptinyx?
Aptinyx paid dividends every year for the past 0 years.
What is the dividend of Aptinyx?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Aptinyx located?
Aptinyx is assigned to the 'Health' sector.
Wann musste ich die Aktien von Aptinyx kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Aptinyx from 12/29/2023 amounting to 0.099 USD, you needed to have the stock in your portfolio before the ex-date on 1/2/2024.
When did Aptinyx pay the last dividend?
The last dividend was paid out on 12/29/2023.
What was the dividend of Aptinyx in the year 2023?
In the year 2023, Aptinyx distributed 0 USD as dividends.
In which currency does Aptinyx pay out the dividend?
The dividends of Aptinyx are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Aptinyx
Our stock analysis for Aptinyx Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Aptinyx Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
